<DOC>
	<DOCNO>NCT00113737</DOCNO>
	<brief_summary>To test whether add fluoxetine pharmacotherapy behavioral cessation treatment improve depression-prone smoker 's ability quit .</brief_summary>
	<brief_title>Fluoxetine Quit Smoking AID Depression Prone</brief_title>
	<detailed_description>DESIGN NARRATIVE : The research treatment-matching study test whether add fluoxetine pharmacotherapy behavioral cessation treatment improve depression-prone smoker 's ability quit . The investigator randomize 144 smoker prior history depression 206 smoker lack history double-blind treatment either 60 mg fluoxetine placebo , underwent cognitive behavioral treatment quit smoking . The main study outcome biologically verify abstinence 6 month treatment . The administration placebo fluoxetine begin 3 week quit smoke date continue 2 month post-quit date ( total 11 week drug/placebo ) . Cognitive behavioral treatment weekly quit biweekly quitting . There monthly follow-up evaluation six month quit date . The research test Selective Benefit Hypothesis Generalized Benefit Hypothesis fluoxetine 's effect . The hypothesis mechanism action drug diminish compulsive smoking behavior , obsessional cigarette craving , nicotine withdrawal dysphoria occur independently depressive vulnerability . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>An estimated 144 smoker prior history depression 206 smoker lack history .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>June 2005</verification_date>
</DOC>